Watching the availability and use of rapid diagnostic tests (RDTs) and artemisinin-based combination therapy (ACT)
Abstract At the turn of this new century and after much debate, the malaria community reckoned with failing first line therapies and moved to a global recommendation for deployment of an artemisinin-based combination therapy (ACT) to treat infections due to Plasmodium falciparum. No one said it was...
Main Authors: | Richard W. Steketee, Thomas P. Eisele |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12936-017-1821-0 |
Similar Items
-
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania
by: Deus S. Ishengoma, et al.
Published: (2019-03-01) -
Malaria healthcare policy change in Kenya: Implications on sales and marketing of antimalarials
by: Peter K. Ngure , Lorraine Nyaoke & David Minja
Published: (2012-03-01) -
High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso
by: Rouamba T, et al.
Published: (2019-02-01) -
Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether–lumefantrine
by: Seif Shekalaghe, et al.
Published: (2020-01-01) -
Safety monitoring experience of single-low dose primaquine co-administered with artemether–lumefantrine among providers and patients in routine healthcare practice: a qualitative study in Eastern Tanzania
by: Dominic Mosha, et al.
Published: (2021-10-01)